SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biolase, Inc. – ‘S-1/A’ on 1/3/23 – ‘EX-23.1’

On:  Tuesday, 1/3/23, at 5:20pm ET   ·   Accession #:  1193125-23-878   ·   File #:  333-268528

Previous ‘S-1’:  ‘S-1/A’ on 12/12/22   ·   Next:  ‘S-1’ on 5/4/23   ·   Latest:  ‘S-1/A’ on 3/27/24   ·   49 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/03/23  Biolase, Inc.                     S-1/A                  6:1M                                     Donnelley … Solutions/FA

Pre-Effective Amendment to Registration Statement (General Form)   —   Form S-1   —   SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Pre-Effective Amendment to Registration Statement   HTML    670K 
                (General Form)                                                   
 2: EX-1.1      Underwriting Agreement or Conflict Minerals Report  HTML    191K 
 3: EX-4.2      Instrument Defining the Rights of Security Holders  HTML     90K 
 4: EX-5.1      Opinion of Counsel re: Legality                     HTML     16K 
 5: EX-23.1     Consent of Expert or Counsel                        HTML      5K 
 6: EX-FILING FEES  Filing Fees                                     HTML     17K 


‘EX-23.1’   —   Consent of Expert or Counsel


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-23.1  

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

BIOLASE, Inc.

Lake Forest, California

We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated March 17, 2022, relating to the consolidated financial statements and schedule of BIOLASE, Inc. appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.

We also consent to the reference to us under the caption “Experts” in the Prospectus.

/s/ BDO USA, LLP

Costa Mesa, California

January 3, 2023


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-1/A’ Filing    Date    Other Filings
Filed on:1/3/23
3/17/2210-K,  8-K
12/31/2110-K
 List all Filings 


8 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/21/24  Biolase, Inc.                     10-K       12/31/23   99:18M                                    Donnelley … Solutions/FA
 1/24/24  Biolase, Inc.                     S-8         1/24/24    4:119K                                   Donnelley … Solutions/FA
 5/24/23  Biolase, Inc.                     S-1/A                  7:1.2M                                   Donnelley … Solutions/FA
 5/22/23  Biolase, Inc.                     S-1/A                  8:1.3M                                   Donnelley … Solutions/FA
 5/18/23  Biolase, Inc.                     S-1/A                  8:1.2M                                   Donnelley … Solutions/FA
 5/11/23  Biolase, Inc.                     10-Q        3/31/23   81:9.9M                                   Donnelley … Solutions/FA
 5/04/23  Biolase, Inc.                     S-1                    3:750K                                   Donnelley … Solutions/FA
 3/28/23  Biolase, Inc.                     10-K       12/31/22   90:19M                                    Donnelley … Solutions/FA


41 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/22/22  Biolase, Inc.                     S-1                    3:655K                                   Donnelley … Solutions/FA
11/10/22  Biolase, Inc.                     10-Q        9/30/22   83:14M                                    Donnelley … Solutions/FA
 9/28/22  Biolase, Inc.                     8-K:1       9/22/22   10:141K                                   Donnelley … Solutions/FA
 8/11/22  Biolase, Inc.                     10-Q        6/30/22   83:16M                                    Donnelley … Solutions/FA
 7/07/22  Biolase, Inc.                     8-K:1,5,7,9 6/30/22   12:172K                                   Donnelley … Solutions/FA
 6/29/22  Biolase, Inc.                     8-K:1,3,8,9 6/27/22   17:749K                                   Donnelley … Solutions/FA
 6/08/22  Biolase, Inc.                     8-K:3,5,7,9 6/08/22   12:10M                                    Donnelley … Solutions/FA
 5/13/22  Biolase, Inc.                     8-K:5       5/11/22   10:138K                                   Donnelley … Solutions/FA
 5/12/22  Biolase, Inc.                     10-Q        3/31/22   81:10M                                    Donnelley … Solutions/FA
 5/02/22  Biolase, Inc.                     8-K:5,9     4/28/22   11:180K                                   Donnelley … Solutions/FA
 3/30/22  Biolase, Inc.                     DEF 14A     4/28/22    1:1.1M                                   Donnelley … Solutions/FA
 3/17/22  Biolase, Inc.                     10-K       12/31/21   88:18M                                    Donnelley … Solutions/FA
 3/03/22  Biolase, Inc.                     8-K:3,5,7,9 3/01/22   13:359K                                   Donnelley … Solutions/FA
11/10/21  Biolase, Inc.                     10-Q        9/30/21   84:13M                                    Donnelley … Solutions/FA
 4/19/21  Biolase, Inc.                     DEF 14A     5/26/21    1:1.2M                                   Donnelley … Solutions/FA
 3/31/21  Biolase, Inc.                     10-K       12/31/20   88:15M                                    ActiveDisclosure/FA
 8/14/20  Biolase, Inc.                     10-Q        6/30/20   89:12M                                    ActiveDisclosure/FA
 6/01/20  Biolase, Inc.                     8-K:5,9     5/28/20    2:26K                                    Donnelley … Solutions/FA
 5/08/20  Biolase, Inc.                     10-Q        3/31/20   86:8.5M                                   ActiveDisclosure/FA
 4/23/20  Biolase, Inc.                     DEF 14A     5/13/20    1:1.5M                                   ActiveDisclosure/FA
 3/30/20  Biolase, Inc.                     10-K       12/31/19   90:24M                                    ActiveDisclosure/FA
11/12/19  Biolase, Inc.                     10-Q        9/30/19   86:10M                                    ActiveDisclosure/FA
10/07/19  Biolase, Inc.                     S-1/A      10/04/19    4:1.7M                                   Donnelley … Solutions/FA
 9/05/19  Biolase, Inc.                     S-1         9/04/19    3:929K                                   Donnelley … Solutions/FA
 5/10/19  Biolase, Inc.                     10-Q        3/31/19   86:8M                                     ActiveDisclosure/FA
 4/10/19  Biolase, Inc.                     DEF 14A     5/15/19    1:971K                                   Donnelley … Solutions/FA
11/14/18  Biolase, Inc.                     10-Q        9/30/18   81:11M                                    ActiveDisclosure/FA
 8/24/18  Biolase, Inc.                     DEF 14A     9/21/18    1:1.6M                                   Donnelley … Solutions/FA
 8/08/18  Biolase, Inc.                     8-K:5,7,9   8/07/18    3:217K                                   ActiveDisclosure/FA
 5/11/18  Biolase, Inc.                     8-K:5,9     5/10/18    2:26K                                    Donnelley … Solutions/FA
 4/05/18  Biolase, Inc.                     DEF 14A     5/09/18    1:717K                                   Donnelley … Solutions/FA
10/03/17  Biolase, Inc.                     8-K:5,7,8,9 9/30/17    4:90K                                    Donnelley Fi… Express/FA
 7/21/17  Biolase, Inc.                     S-3                    4:281K                                   ActiveDisclosure/FA
 4/07/16  Biolase, Inc.                     DEF 14A     5/06/16    1:1M                                     Donnelley … Solutions/FA
11/06/15  Biolase, Inc.                     10-Q        9/30/15   68:7.2M                                   ActiveDisclosure/FA
11/04/14  Biolase, Inc.                     8-A12B/A               3:38K                                    Donnelley … Solutions/FA
 5/16/12  Biolase, Inc.                     8-K:5,7,9   5/10/12    3:44K                                    Donnelley Fi… Express/FA
12/23/05  Biolase, Inc.                     S-1/A                  6:2.3M                                   Donnelley … Solutions/FA
11/09/05  Biolase, Inc.                     10-Q        9/30/05    9:771K                                   Donnelley … Solutions/FA
 7/19/05  Biolase, Inc.                     10-K       12/31/04   17:2.2M                                   Donnelley … Solutions/FA
 6/03/02  Biolase, Inc.                     S-3                    6:225K                                   Donnelley R R & S… 11/FA
Top
Filing Submission 0001193125-23-000878   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 8:48:38.3am ET